SynAct Pharma Balance Sheet Health
Financial Health criteria checks 6/6
SynAct Pharma has a total shareholder equity of SEK176.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK228.0M and SEK51.8M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr62.40m |
Equity | kr176.19m |
Total liabilities | kr51.83m |
Total assets | kr228.02m |
Recent financial health updates
Here's Why We're Watching SynAct Pharma's (STO:SYNACT) Cash Burn Situation
Sep 04Is SynAct Pharma (NGM:SYNACT) In A Good Position To Deliver On Growth Plans?
Jan 18Here's Why We're Not Too Worried About SynAct Pharma's (NGM:SYNACT) Cash Burn Situation
Sep 03SynAct Pharma (NGM:SYNACT) Is In A Good Position To Deliver On Growth Plans
Apr 07Companies Like SynAct Pharma (NGM:SYNACT) Are In A Position To Invest In Growth
Dec 23Recent updates
Here's Why We're Watching SynAct Pharma's (STO:SYNACT) Cash Burn Situation
Sep 04Is SynAct Pharma (NGM:SYNACT) In A Good Position To Deliver On Growth Plans?
Jan 18Here's Why We're Not Too Worried About SynAct Pharma's (NGM:SYNACT) Cash Burn Situation
Sep 03SynAct Pharma (NGM:SYNACT) Is In A Good Position To Deliver On Growth Plans
Apr 07Companies Like SynAct Pharma (NGM:SYNACT) Are In A Position To Invest In Growth
Dec 23Financial Position Analysis
Short Term Liabilities: SYNACT's short term assets (SEK75.1M) exceed its short term liabilities (SEK24.9M).
Long Term Liabilities: SYNACT's short term assets (SEK75.1M) exceed its long term liabilities (SEK26.9M).
Debt to Equity History and Analysis
Debt Level: SYNACT is debt free.
Reducing Debt: SYNACT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SYNACT has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: SYNACT is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.